Elevai Labs, Inc. (NASDAQ:ELAB) Sees Significant Drop in Short Interest

Elevai Labs, Inc. (NASDAQ:ELAB) was the target of a large decrease in short interest in February. As of February 28th, there was short interest totalling 19,400 shares, a decrease of 89.6% from the February 13th total of 185,700 shares. Currently, 0.6% of the company’s shares are sold short. Based on an average daily volume of 302,600 shares, the days-to-cover ratio is currently 0.1 days.

Elevai Labs Stock Up 8.4 %

Shares of Elevai Labs stock traded up $0.35 during trading on Thursday, hitting $4.46. The company’s stock had a trading volume of 19,109 shares, compared to its average volume of 305,178. The company has a debt-to-equity ratio of 0.06, a quick ratio of 3.40 and a current ratio of 3.86. The company has a fifty day simple moving average of $12.36 and a two-hundred day simple moving average of $97.62. The company has a market capitalization of $2.57 million, a PE ratio of -0.07 and a beta of -2.93. Elevai Labs has a 52 week low of $3.88 and a 52 week high of $1,134.00.

Elevai Labs Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.